The global Drugs for Treatment of Erectile Dysfunction market was valued at USD 41.25 Billion in 2015, and is projected to reach USD 54.84 Billion by 2021, at a CAGR of 5.86% between 2016 and 2021. The market is projected witness significant growth in the coming years, owing to the aging population increase, increased incidence and development of new drugs
This report studies Drugs for Treatment of Erectile Dysfunction in Global and China market, focuses on price, sales, market share and revenue of each type in global China. This report also focuses on the sales (consumption), production and market share of Drugs for Treatment of Erectile Dysfunction in US, Europe Union and China, forecast to 2020, from 2015.
Split by product types, with sales, revenue, market share and price of each type, as well as the types and each type price of key manufacturers, through interviewing key manufacturers, in 2015 and 2016, covering
Sildenafil Citrate Tablets
Split by manufacturers, this report focuses on the sales, price of each type, average price of Treatment of Erectile Dysfunction, revenue and market share, for each manufacturer in 2015 and 2016. Top players, covering
Bayer Schering Pharma AG
Topfond pharmaceutical Limited by Share Ltd
Tianjin Lisheng Pharmaceutical
Pharmaceutical Factory, Guangzhou Baiyun Mountain
Liaoning Green Biological Pharmaceutical Group
Harbin Pharmaceutical Group
Split by regions, this report focuses on the sales (consumption), market share by manufacturer of Drugs for Treatment of Erectile Dysfunction in US, EU and China, from 2011 to 2020 (forecast), covering
With 116 pages, 130 charts and eight chapters, to display the market present situation and future, clearly and deeply.